SCHEMBL19080104

SCHEMBL19080104

c1ccc2cc(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7c(c6)c6ccccc6c6c8cc9ccccc9cc8oc76)ccc5c4)c4ccccc34)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.39
CYP1B1 Q16678 2/20 0.39
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
ALOX5 P09917 2/20 0.33
GPR84 Q9NQS5 1/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
ARSA P15289 1/20 0.32
CDC25A P30304 1/20 0.32
CDC25C P30307 1/20 0.32
HPGD P15428 3/20 0.32
HSD17B10 Q99714 3/20 0.32
CYP3A4 P08684 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALPI P09923 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079997 0.97 CYP1A1 (0.37) CYP1A1CYP1B1ESR1ESR2ALOX5
SCHEMBL19080040 0.95 ESR1 (0.37) CYP1A1CYP1B1ESR1ESR2GPR84
SCHEMBL19080109 0.95 CYP1A1 (0.37) CYP1A1CYP1B1ESR1ESR2ALOX5
SCHEMBL19080009 0.93 CYP1A1 (0.37) CYP1A1CYP1B1ESR1ESR2ALOX5
SCHEMBL19079991 0.92 ESR1 (0.36) CYP1A1CYP1B1ESR1ESR2ALOX5
SCHEMBL19080085 0.92 CYP1A1 (0.35) CYP1A1CYP1B1ALOX5GPR84ARSA
SCHEMBL16067805 0.91 CYP1A1 (0.39) CYP1A1CYP1B1ESR1ESR2ALOX5
SCHEMBL19080071 0.91 SOS1 (0.34) CYP1A1CYP1B1ALOX5ARSACDC25A
SCHEMBL17577240 0.90 CYP1A1 (0.37) CYP1A1CYP1B1ESR1ESR2GPR84
SCHEMBL17577238 0.90 CYP1A1 (0.37) CYP1A1CYP1B1ESR1ESR2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ESR1 153/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 CYP1A1 147/4885CYP1B1 225/4885ESR1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.